SANOCHEMIA Pharmazeutika GmbH
Landegger Straße 7 und 33 A-2491
Neufeld an der Leitha

Wide range of services

Because we put quality first

With the development, production and distribution of pharmaceutical specialties, we have been contributing to people’s health for more than 30 years. Our strengths include the development and manufacture of sterile liquid dosage forms and small molecule active pharmaceutical ingredients. For our own needs and as CDMO for third parties.

Imaging Agents

In Austria, we develop, produce and distribute some of the most established generic imaging agents under the Sanochemia brand. Our products help physicians make efficient therapeutic decisions for patients.

Contract Manufacturing

With contract manufacturing of sterile and low-bioburden liquids as well as APIs, we offer in-depth expertise in the field of drug product and API production. As a full-service provider, we also support with GMP services.

API

Our focus on high-quality API synthesis completes our “made in Austria” offering. Innovative APIs for the treatment of muscle spasms and Alzheimer’s disease are produced and distributed by Sanochemia.

TRUSTED PARTNER
FOR THE PHARMACEUTICAL INDUSTRY
Pharmaceutical specialties from Austria
We put our customers first. Are you looking for a
competent partner for your drug product or active ingredient production?
Always remain up to date
New record on order volumes and capacity expansion at Sanochemia Pharmazeutika

New record on order volumes and capacity expansion at Sanochemia Pharmazeutika

The registration initiative launched by Sanochemia Pharmazeutika in 2021, together with the continuously increasing market demand, has led to a record volume of orders.

Read more
1200 450 Sanochemia
New contrast agent aims to detect the smallest lymphatic metastases in prostate cancer
Signing Ferrotran ECR 2024 Sanochemia

New contrast agent aims to detect the smallest lymphatic metastases in prostate cancer

Sanochemia Pharmazeutika secures exclusive licensing rights to a new MRI contrast agent based on ferumoxtran, that is in an advanced pivotal trial in clinical phase III and may be used to detect the smallest lymph node metastases in prostate cancer patients. The product is already deployed in the Netherlands within an authorized Named-Patient-Use-Program (Artsenverklaring).

Read more
1200 450 Sanochemia
Sanochemia initiates global roll-out of an Iron-based MRI contrast agent for the liver

Sanochemia initiates global roll-out of an Iron-based MRI contrast agent for the liver

Sanochemia Pharmazeutika is strengthening its position in the field of medical imaging with an exclusive product license for a MRI contrast agent based on iron-containing nanoparticles under the brand name Resotran®.

Read more
1200 450 Sanochemia
Wenn Sie unsere Website besuchen, können über Ihren Browser Informationen von bestimmten Diensten gespeichert werden, in der Regel in Form von Cookies. Hier können Sie Ihre Datenschutzeinstellungen ändern. Bitte beachten Sie, dass die Blockierung einiger Arten von Cookies Ihre Erfahrung auf unserer Website beeinträchtigen kann.
 
 
  •  
Unsere Website verwendet Cookies, hauptsächlich von Drittanbietern. Definieren Sie Ihre Datenschutzpräferenzen und/oder stimmen Sie unserer Verwendung von Cookies zu. Mit diesen Cookies werden von uns und von Drittanbietern (die auch in den USA niedergelassen sind) mitunter personenbezogene Daten verarbeitet. Den USA wird vom Europäischen Gerichtshof kein angemessenes Datenschutzniveau bescheinigt. Es besteht insbesondere das Risiko, dass Ihre Daten dem Zugriff durch US-Behörden zu Kontroll- und Überwachungszwecken unterliegen und dagegen keine wirksamen Rechtsbehelfe zur Verfügung stehen. Mit Ihrem Klick auf „Ja, alle Cookies akzeptieren“ stimmen Sie zu, dass Cookies von uns und von Drittanbietern (auch in den USA) verwendet werden dürfen.